Cantabio Pharmaceuticals Stock Market Value

CTBO Stock  USD 1.01  0.00  0.00%   
Cantabio Pharmaceuticals' market value is the price at which a share of Cantabio Pharmaceuticals trades on a public exchange. It measures the collective expectations of Cantabio Pharmaceuticals investors about its performance. Cantabio Pharmaceuticals is selling at 1.01 as of the 11th of February 2026; that is No Change since the beginning of the trading day. The stock's open price was 1.01.
With this module, you can estimate the performance of a buy and hold strategy of Cantabio Pharmaceuticals and determine expected loss or profit from investing in Cantabio Pharmaceuticals over a given investment horizon. Check out Cantabio Pharmaceuticals Correlation, Cantabio Pharmaceuticals Volatility and Cantabio Pharmaceuticals Performance module to complement your research on Cantabio Pharmaceuticals.
Symbol

It's important to distinguish between Cantabio Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cantabio Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Cantabio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Cantabio Pharmaceuticals 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cantabio Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cantabio Pharmaceuticals.
0.00
11/13/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/11/2026
0.00
If you would invest  0.00  in Cantabio Pharmaceuticals on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Cantabio Pharmaceuticals or generate 0.0% return on investment in Cantabio Pharmaceuticals over 90 days. Cantabio Pharmaceuticals, Inc., a preclinical stage biotechnology company, focuses on the research, development, and com... More

Cantabio Pharmaceuticals Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cantabio Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cantabio Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.

Cantabio Pharmaceuticals Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Cantabio Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cantabio Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Cantabio Pharmaceuticals historical prices to predict the future Cantabio Pharmaceuticals' volatility.
Hype
Prediction
LowEstimatedHigh
1.011.011.01
Details
Intrinsic
Valuation
LowRealHigh
1.011.011.01
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cantabio Pharmaceuticals. Your research has to be compared to or analyzed against Cantabio Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Cantabio Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Cantabio Pharmaceuticals.

Cantabio Pharmaceuticals Backtested Returns

We have found three technical indicators for Cantabio Pharmaceuticals, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Cantabio Pharmaceuticals are completely uncorrelated.

Auto-correlation

    
  0.00  

No correlation between past and present

Cantabio Pharmaceuticals has no correlation between past and present. Overlapping area represents the amount of predictability between Cantabio Pharmaceuticals time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cantabio Pharmaceuticals price movement. The serial correlation of 0.0 indicates that just 0.0% of current Cantabio Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.0

Other Information on Investing in Cantabio Pink Sheet

Cantabio Pharmaceuticals financial ratios help investors to determine whether Cantabio Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cantabio with respect to the benefits of owning Cantabio Pharmaceuticals security.